Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

CAPR Capricor Therapeutics Inc

14,9881

1,19 (8,61%)

03 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Capricor Therapeutics (NASDAQ:CAPR)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Capricor Therapeutics Charts.

Capricor Therapeutics (NASDAQ:CAPR)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Capricor Therapeutics Charts.

News Capricor Therapeutics Inc

Form 8-K - Current report
Donnerstag 2 Januar 2025 (8 Stunden vor) • Edgar (US Regulatory)

Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
Donnerstag 2 Januar 2025 (13 Stunden vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Montag 16 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 5 Dezember 2024 (4 Wochen vor) • Edgar (US Regulatory)

Capricor Therapeutics to Present at Upcoming Investor Conferences
Montag 2 Dezember 2024 (1 Monat vor) • GlobeNewswire Inc.

Capricor Therapeutics Granted Orphan Drug and ATMP Status for Deramiocel by European Medicines Agency
Mittwoch 20 November 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 13 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Mittwoch 13 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Dienstag 12 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Capricor Therapeutics to Present Exosome Platform Updates at 2024 American Association of Extracellular Vesicles Annual Meeting
Dienstag 12 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Dienstag 12 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Capricor Therapeutics Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen